These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24791591)

  • 1. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
    Al-Omari MM; Abdelah MK; Badwan AA; Jaber AM
    J Pharm Biomed Anal; 2001 Jul; 25(5-6):893-902. PubMed ID: 11377072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM; dos Santos LD; Lima EM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures.
    Vehovec T; Gartner A; Planinšek O; Obreza A
    Acta Pharm; 2012 Dec; 62(4):515-28. PubMed ID: 23333887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new impurities of enalapril maleate on oxidation in the presence of magnesium monoperoxyphthalate.
    Toporisic R; Mlakar A; Hvala J; Prislan I; Zupancic-Kralj L
    J Pharm Biomed Anal; 2010 Jun; 52(2):294-9. PubMed ID: 20122808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B
    Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
    Eyjolfsson R
    Pharmazie; 2002 May; 57(5):347-8. PubMed ID: 12061263
    [No Abstract]   [Full Text] [Related]  

  • 11. The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability.
    Stanisz B
    Acta Pol Pharm; 1999; 56(6):431-4. PubMed ID: 10715888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.
    Szabó ZI; Székely-Szentmiklósi B; Deák B; Székely-Szentmiklósi I; Kovács B; Zöldi K; Sipos E
    Acta Pharm; 2016 Jun; 66(2):191-206. PubMed ID: 27279063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril maleate form II: stabilization in a tablet formulation.
    Eyjolfsson R
    Pharmazie; 2003 May; 58(5):357. PubMed ID: 12779058
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit E accelerated the diketopiperazine formation of enalapril maleate determined by thermal FTIR microspectroscopic technique.
    Wang SL; Lin SY; Chen TF; Cheng WT
    Pharm Res; 2004 Nov; 21(11):2127-32. PubMed ID: 15587937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of stearic acid on enalapril stability and dissolution from multiparticulate solid dosage forms.
    Cunha TA; Serpa RC; de Oliveira AP; Nasser LN; de Freitas LA; Taveira SF; Diniz DG; Lima EM; Marreto RN
    AAPS PharmSciTech; 2013 Sep; 14(3):1150-7. PubMed ID: 23897034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular cyclization of diketopiperazine formation in solid-state enalapril maleate studied by thermal FT-IR microscopic system.
    Lin SY; Wang SL; Chen TF; Hu TC
    Eur J Pharm Biopharm; 2002 Sep; 54(2):249-54. PubMed ID: 12191699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pulsatile drug delivery system based on the physiochemical reaction between acrylic copolymer and organic acid: in vitro and in vivo evaluation.
    Zhang Z; Qi X; Li X; Xing J; Zhu X; Wu Z
    Int J Pharm; 2014 Feb; 462(1-2):66-73. PubMed ID: 24368107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction kinetics of solid-state cyclization of enalapril maleate investigated by isothermal FT-IR microscopic system.
    Wang SL; Lin SY; Chen TF
    Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):402-6. PubMed ID: 11310665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.